151 related articles for article (PubMed ID: 7633653)
1. Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies--comparative studies on frozen and paraffin sections.
Remmele W; Mühlfait V; Keul HG
Virchows Arch; 1995; 426(5):435-9. PubMed ID: 7633653
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity to MIB-1 in breast cancer: methodological assessment and comparison with other proliferation indices.
Benini E; Rao S; Daidone MG; Pilotti S; Silvestrini R
Cell Prolif; 1997; 30(3-4):107-15. PubMed ID: 9375023
[TBL] [Abstract][Full Text] [Related]
3. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
5. Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
Noordzij MA; van der Kwast TH; van Steenbrugge GJ; van Weerden WM; Oomen MH; Schröder FH
Prostate; 1995 Sep; 27(3):154-9. PubMed ID: 7567694
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
[TBL] [Abstract][Full Text] [Related]
8. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
10. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
11. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
12. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
13. [Ki-67 in carcinoma of the breast: from the frozen to the paraffin sections].
Ghidoni D; Folicaldi S; Errani E; Borgini B; Bondi A
Pathologica; 1996 Aug; 88(4):270-4. PubMed ID: 9005395
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
Weidner N; Moore DH; Vartanian R
Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
[TBL] [Abstract][Full Text] [Related]
15. Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B
Cytometry; 1997 Mar; 27(3):283-9. PubMed ID: 9041118
[TBL] [Abstract][Full Text] [Related]
16. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
Ellis PA; Makris A; Burton SA; Titley J; Ormerod MG; Salter J; Powles TJ; Smith IE; Dowsett M
Br J Cancer; 1996 Mar; 73(5):640-3. PubMed ID: 8605100
[TBL] [Abstract][Full Text] [Related]
17. Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: estimation of whole tumor proliferative potential using biopsy specimens.
Oda K; Yokoi S; Kanda H; Shibuya M; Kamiya S; Horisawa M; Niinomi N; Suzuki M; Hayakawa S; Kishikawa S
Tokai J Exp Clin Med; 1995 Jul; 20(2):81-8. PubMed ID: 8797264
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
Skalova A; Leivo I; Von Boguslawsky K; Saksela E
J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
[TBL] [Abstract][Full Text] [Related]
19. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
20. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
